The IPO Buzz: Biotech Alumis (ALMS) Priced Slimmer IPO at $16.00 – Low End
Alumis (ALMS), a psoriasis-focused biotech, downsized its IPO and priced it at $16.00 – the low end of its range – to raise $210.0 million on Thursday night, June 27, 2024. The IPO’s size was trimmed to 13.125 million shares at pricing – down from 17.65 million shares in the prospectus. The IPO price – $16.00 […]
June 28, 2024 Read More